Search

everythinglearnresearchcommunity

for

Search:↓

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

The FUET method improves hair transplant precision and outcomes by combining FUT and FUE techniques under a surgeon's control.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The document's conclusion cannot be provided because the text is not in a processable format.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Baricitinib works better than methotrexate for severe alopecia areata.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Polyethylene alanine caused hair loss in young lab animals but not in adults, with hair regrowth occurring within 20 days.

Most antiandrogen treatments effectively reduce acne in hyperandrogenic women, but finasteride is the least effective.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

A man regrew hair after using a specific cream for skin treatment.

Adiantum capillus extract reduces pain and swelling in animals.